HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ronald A Lubet Selected Research

polyphenon E

6/2010Effect of dietary Polyphenon E and EGCG on lung tumorigenesis in A/J Mice.
6/2009Lung cancer inhibitory effect of epigallocatechin-3-gallate is dependent on its presence in a complex mixture (polyphenon E).
7/2007Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols.
2/2006A gene expression signature that can predict green tea exposure and chemopreventive efficacy of lung cancer in mice.
1/2006Efficacy of polyphenon E, red ginseng, and rapamycin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ronald A Lubet Research Topics

Disease

121Neoplasms (Cancer)
01/2022 - 04/2002
56Carcinogenesis
01/2021 - 06/2002
30Lung Neoplasms (Lung Cancer)
11/2019 - 01/2003
29Breast Neoplasms (Breast Cancer)
01/2021 - 02/2004
17Body Weight (Weight, Body)
09/2017 - 12/2005
16Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 09/2004
16Adenoma (Adenomas)
11/2019 - 06/2002
11Adenocarcinoma
11/2019 - 04/2002
11Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2019 - 03/2002
10Carcinoma (Carcinomatosis)
11/2019 - 06/2002
9Colonic Neoplasms (Colon Cancer)
01/2022 - 09/2002
7Adenocarcinoma of Lung
10/2019 - 03/2002
5Skin Neoplasms (Skin Cancer)
09/2012 - 05/2003
5Prostatic Neoplasms (Prostate Cancer)
03/2010 - 09/2002
4Inflammation (Inflammations)
12/2010 - 12/2002
3Mouth Neoplasms (Oral Cancer)
01/2015 - 01/2010
3Squamous Cell Carcinoma of Head and Neck
01/2015 - 01/2010
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2013 - 05/2006
2Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

26Biomarkers (Surrogate Marker)IBA
01/2020 - 07/2002
23CarcinogensIBA
01/2021 - 08/2003
22Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
01/2021 - 02/2005
16Bexarotene (LGD1069)FDA Link
01/2020 - 02/2005
13Pharmaceutical PreparationsIBA
01/2022 - 10/2004
12RNA (Ribonucleic Acid)IBA
01/2022 - 09/2004
12Budesonide (Pulmicort)FDA LinkGeneric
04/2019 - 07/2002
11Benzo(a)pyreneIBA
06/2015 - 05/2003
10Naproxen (Naprosyn)FDA LinkGeneric
01/2022 - 11/2009
10Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2002
10hydroxide ionIBA
01/2020 - 03/2005
9Gefitinib (Iressa)FDA Link
01/2020 - 12/2006
9Estrogen ReceptorsIBA
01/2020 - 10/2004
9vinyl carbamateIBA
09/2012 - 07/2002
8Messenger RNA (mRNA)IBA
09/2012 - 09/2002
8SmokeIBA
01/2007 - 02/2003
7Celecoxib (Celebrex)FDA Link
01/2022 - 05/2003
7Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022 - 11/2009
7AzoxymethaneIBA
01/2021 - 02/2004
6VaccinesIBA
01/2021 - 12/2013
6TamoxifenFDA LinkGeneric
01/2020 - 07/2006
6NitrosaminesIBA
09/2017 - 09/2004
6DNA (Deoxyribonucleic Acid)IBA
03/2007 - 02/2004
5Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2022 - 01/2008
5Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2019 - 07/2002
5Caspase 3 (Caspase-3)IBA
11/2019 - 03/2007
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2019 - 02/2004
5GlucocorticoidsIBA
04/2019 - 10/2004
5Lapatinib (GW572016)FDA Link
01/2019 - 08/2011
5Pioglitazone (Actos)FDA Link
07/2017 - 11/2010
5ErbB Receptors (EGF Receptor)IBA
11/2016 - 12/2006
5Sulindac (Copal)FDA LinkGeneric
02/2014 - 09/2002
5TeaIBA
01/2014 - 02/2006
5Biological ProductsIBA
09/2012 - 07/2002
5RetinoidsIBA
09/2012 - 09/2002
5polyphenon EIBA
06/2010 - 01/2006
5tipifarnib (R115777)IBA
01/2007 - 05/2003
4vorozoleIBA
01/2020 - 04/2008
4Insulin (Novolin)FDA Link
09/2017 - 10/2002
44-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA
01/2015 - 06/2006
4Eflornithine (Ornidyl)FDA Link
02/2014 - 12/2002
4LigandsIBA
01/2013 - 08/2005
4Piroxicam (Feldene)FDA LinkGeneric
01/2010 - 06/2002
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2010 - 12/2002
4Retinoid X Receptors (Retinoid X Receptor)IBA
12/2009 - 06/2006
4OligonucleotidesIBA
07/2006 - 02/2004
4AlitretinoinFDA Link
06/2006 - 09/2002
3Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2022 - 02/2003
3Peptides (Polypeptides)IBA
01/2021 - 11/2016
3AntigensIBA
01/2021 - 12/2013
3Atorvastatin (Lipitor)FDA Link
01/2020 - 02/2009
3Metformin (Glucophage)FDA LinkGeneric
01/2020 - 03/2015
3Dinoprostone (PGE2)FDA Link
11/2019 - 12/2002
3AerosolsIBA
10/2019 - 06/2009
3Aromatase InhibitorsIBA
09/2018 - 01/2008
3Rosiglitazone (Avandia)FDA Link
01/2015 - 08/2005
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2015 - 11/2010
3retinamideIBA
09/2012 - 02/2004
3Estrogens (Estrogen)FDA Link
03/2012 - 07/2006
3FlavonoidsIBA
01/2012 - 12/2010
3Phosphotransferases (Kinase)IBA
11/2011 - 07/2006
3AndrogensIBA
03/2010 - 01/2007
3SurvivinIBA
03/2008 - 03/2005
3ProstaglandinsIBA
03/2008 - 05/2003
3TransferasesIBA
01/2007 - 04/2006
3Farnesyltranstransferase (Farnesyltransferase)IBA
07/2006 - 05/2003
2Immune Checkpoint ProteinsIBA
01/2022 - 01/2021
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2021 - 11/2010
2Protein Subunit VaccinesIBA
01/2021 - 10/2017
2Cyclin D1IBA
01/2020 - 03/2008
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020 - 05/2013
2CholesterolIBA
11/2019 - 10/2007
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2019 - 05/2011
2MicroRNAs (MicroRNA)IBA
04/2019 - 02/2012
2Insulin-Like PeptidesIBA
06/2015 - 10/2002
2Sirolimus (Rapamycin)FDA Link
04/2015 - 01/2006
2Drinking WaterIBA
01/2015 - 01/2006

Therapy/Procedure

44Chemoprevention
01/2022 - 06/2002
15Therapeutics
06/2015 - 05/2003
4Oral Administration
11/2011 - 10/2004
3Aftercare (After-Treatment)
04/2019 - 10/2002